Fibroblast Growth Factor 23 (FGF23) Predicts Progression of Chronic Kidney Disease: The Mild to Moderate Kidney Disease (MMKD) Study
This article is a cohort study of non diabetic patients with chronic kidney disease which shows that fibroblast growth factor 23 (FGF23) is an independent predictor of progression of chronic kidney disease.
$ 0.043
8